Welcome!

News Feed Item

The Overtreatment Conundrum: Definiens Identifies Three Steps for Advancing Diagnostics to Reduce Unnecessary Cancer Treatment and Improve Patient Health

Definiens, the global leader in Tissue Phenomics™ for diagnostics development in oncology, today released tips for the development of diagnostics to help physicians make more informed decisions, reduce unnecessary treatment and improve overall patient health. As the global cost of cancer care continues to rise exponentially, tests based on data generated from the analysis of tissue samples can play a critical role in helping improve stratification to provide patients with effective personalized care.

The overtreatment of cancer represents a significant and complex issue from both a health economics and patient care perspective. Studies published in the New England Journal of Medicine report “the annual direct costs of cancer care are projected to rise from $104 billion in 2006 to over $173 billion in 2020.” The problem, however, is that the current clinical and pathological parameters for diagnosing many cancer-types fail to accurately segment individual patients into specific risk groups. Many patients with low to intermediate stage cancers often receive the same level of aggressive treatment administered to patients with advanced, late-stage cancers. The result? Much of the money is spent on treatments that are unnecessary; leaving many patients needlessly exposed to potentially harmful side effects and long-term health consequences.

“The pervasive problem of cancer overtreatment highlights the urgent need for tests that can improve stratification in order to accurately identify those patient groups that require aggressive treatment, while allowing clinicians to separate out low-risk patients that will benefit from active surveillance,” said Dr. Ralf Huss, Chief Medical Officer of Definiens. “Definiens Tissue Phenomics™ solutions provides researchers with the necessary tools to extract, analyze and correlate all relevant data from heterogeneous tissue samples in order to develop innovative diagnostic tests with the capacity to inform better treatment decisions, lower healthcare costs and meet the needs of individual patients.”

Definiens’ three steps for the development of diagnostics that can reduce unnecessary cancer treatment and improve patient health include:

1. Recognize the Importance of Analyzing Intact Tissue

Over the past decade, advancements in next generation sequencing have proven essential for the molecular subgrouping of patients on the basis of genomic data. However, because there is only partial correlation between gene mutations, gene expression and actual tumor behavior, genomic information alone only provides a first-stage projection of cancer development. Conversely, focusing on the data that resides in intact tissue samples, including the number, shape, size and morphology of different structures and cells and proteins active in and around the tumor, will allow researchers to derive a more precise understanding of tumor biology and identify more effective biomarkers as result.

2. Focus on the Entire Tumor Microenvironment

Among researchers, a focus on genomics has often led to a preoccupation with the tumor itself. However, recent advances in immunotherapy indicate that the development of effective tests that have the ability to determine the likelihood of tumor recurrence and long-term treatment success require image analysis of the entire tumor microenvironment. This includes an understanding of the ways in which cancer cells change and grow in relation to surrounding cellular tissue. Looking at the larger context in which the tumor exists can better inform treatment decisions by providing invaluable insights regarding the probability of cancer progression.

3. Take a Big Data Approach to Tissue Analysis

To be sure, the data that resides in tissue samples is both vast and heterogeneous. Consequently, it is also far too complex and voluminous for human analysis alone. Automated image analysis and data mining that can fully quantify and extract all of the data that resides in tissue samples are critical for the development of tests with real prognostic value. In this regard, a big data approach that allows researchers to correlate information from multiple sources, including complex tissue signatures and genomic profiles, can provide the comprehensive picture needed for superior personalized and targeted treatment decisions.

About Definiens

Definiens is the global leader in Tissue Phenomics™ for discovery and diagnostics development in oncology and provides image analysis solutions for life sciences. Definiens' technology provides detailed tissue biomarker readouts from slide images and enables the correlation of this information with other key clinical or genomic information, an approach known as Tissue Phenomics™. Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and support better decisions in research, diagnostics and therapy.

Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine, and to significantly improve the quality of patients' lives. Definiens is headquartered in Munich, Germany and has its North American headquarters in Carlsbad, CA. Further information is available at www.definiens.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...
Interested in leveling up on your Cloud Foundry skills? Join IBM for Cloud Foundry Days on June 7 at Cloud Expo New York at the Javits Center in New York City. Cloud Foundry Days is a free half day educational conference and networking event. Come find out why Cloud Foundry is the industry's fastest-growing and most adopted cloud application platform.
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assis...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
SYS-CON Events announced today that Carbonite will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Carbonite protects your entire IT footprint with the right level of protection for each workload, ensuring lower costs and dependable solutions with DoubleTake and Evault.
SYS-CON Events announced today that EARP Integration will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. EARP Integration is a passionate software house. Since its inception in 2009 the company successfully delivers smart solutions for cities and factories that start their digital transformation. EARP provides bespoke solutions like, for example, advanced enterprise portals, business intelligence systems an...
In his session at 20th Cloud Expo, Brad Winett, Senior Technologist for DDN Storage, will present several current, end-user environments that are using object storage at scale for cloud deployments including private cloud and cloud providers. Details on the top considerations of features and functions for selecting object storage will be included. Brad will also touch on recent developments in tiering technologies that deliver single solution and an end-user view of data across files and objects...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...
We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which i...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 20th Cloud Expo, Tom Eck, Industry Platforms CTO at IBM Cloud, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing developer...